FDA Approved: TOBRAMYCIN INHALATION — Supplemental Application (Prasco, LLC)

View source ↗

Summary

The FDA approved a supplemental application for Tobramycin Inhalation by Prasco, LLC, expanding the approved labeling for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• TOBRAMYCIN INHALATION (TOBRAMYCIN)

Snippet

SUPPL AP for TOBRAMYCIN INHALATION (TOBRAMYCIN INHALATION)